Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Plos One
|
May 22, 2013
Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity
Irma Pujol-Autonell, Rosa-Maria Ampudia, Raquel Planas, et al.
Brain : a Journal of Neurology
|
October 17, 2025
Apathy, effort-based decisions and brain integrity in Alzheimer's and Parkinson's diseases
Lee-Anne Morris, Hideo Suzuki, Seonjoo Lee, et al.
Leukemia & Lymphoma
|
January 20, 2022
A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia
Panayiotis Panayiotidis, Gayane Tumyan, Catherine Thieblemont, et al.
Molecular Brain
|
August 7, 2009
cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake
Jennifer A Steiner, Ana Marin D Carneiro, Jane Wright, et al.
Biomolecules
|
May 28, 2025
Examining the Effects of the RUNX1 p.Leu43Ser Variant on FPD/AML Phenotypes Using a CRISPR/Cas9-Generated Knock-In Murine Model
Ana Marin-Quilez, Ignacio García-Tuñón, Rocío Benito, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 5, 2020
Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells
Evelyn Susanto, Ana Marin Navarro, Leilei Zhou, et al.
Annals of Medicine
|
April 17, 2019
Identification of novel variants in ten patients with Hermansky-Pudlak syndrome by high-throughput sequencing
Jose María Bastida, Sara Morais, Veronica Palma-Barqueros, et al.
Blood
|
July 5, 2022
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse
Chiara Rusconi, Chan Y Cheah, Toby A Eyre, et al.
Blood
|
May 16, 2024
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study
Chiara Malinverni, Andrea Bernardelli, Ingrid Glimelius, et al.
Leukemia
|
August 13, 2020
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study
Carlo Visco, Alice Di Rocco, Andrea Evangelista, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Plos One
|
May 22, 2013
Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity
Irma Pujol-Autonell, Rosa-Maria Ampudia, Raquel Planas, et al.
Brain : a Journal of Neurology
|
October 17, 2025
Apathy, effort-based decisions and brain integrity in Alzheimer's and Parkinson's diseases
Lee-Anne Morris, Hideo Suzuki, Seonjoo Lee, et al.
Leukemia & Lymphoma
|
January 20, 2022
A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia
Panayiotis Panayiotidis, Gayane Tumyan, Catherine Thieblemont, et al.
Molecular Brain
|
August 7, 2009
cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake
Jennifer A Steiner, Ana Marin D Carneiro, Jane Wright, et al.
Biomolecules
|
May 28, 2025
Examining the Effects of the RUNX1 p.Leu43Ser Variant on FPD/AML Phenotypes Using a CRISPR/Cas9-Generated Knock-In Murine Model
Ana Marin-Quilez, Ignacio García-Tuñón, Rocío Benito, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 5, 2020
Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells
Evelyn Susanto, Ana Marin Navarro, Leilei Zhou, et al.
Annals of Medicine
|
April 17, 2019
Identification of novel variants in ten patients with Hermansky-Pudlak syndrome by high-throughput sequencing
Jose María Bastida, Sara Morais, Veronica Palma-Barqueros, et al.
Blood
|
July 5, 2022
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse
Chiara Rusconi, Chan Y Cheah, Toby A Eyre, et al.
Blood
|
May 16, 2024
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study
Chiara Malinverni, Andrea Bernardelli, Ingrid Glimelius, et al.
Leukemia
|
August 13, 2020
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study
Carlo Visco, Alice Di Rocco, Andrea Evangelista, et al.
Page
of 6